A global R&D treaty could boost innovation and improve the health of the world’s poor—and rich.

About 5,000 scientists are expected to attend the 1994 annual meeting of the American Association for the Advancement of Science, to be held in San Francisco February 18-23. * John Gibbons, Assistant to the President of the United States for Science and Technology, and Director of the Office of Science and Technology Policy: "Science, Technology, and the Clinton Administration." * "Health Care Reform and Advances in Medicine":

Agronomic sciences should follow the lead of genetics and other disciplines in sharing data.

This year, US politics was dominated by the run-up to October elections, with science policy issues playing a role here and elsewhere around the world.

Race has been used to segment humanity and, by extension, establish and enforce a hierarchy in science. Individual and institutional commitments to racial justice in the sciences must involve political activity.

Two new medications for treating a rare and deadly neuromuscular disease have high prices and questionable efficacies, say scientists.

NIH, NSF, and the DOE’s Office of Science will be among the agencies with budget increases if the omnibus bill is passed.

This year’s crop of winning products features many with a clinical focus and others that represent significant advances in sequencing, single-cell analysis, and more.

Secrets to scoring big money grants for innovative, out-of-the-box research

These new initiatives would tackle problems relating to health and climate.